[go: up one dir, main page]

PT92649A - Processo para a preparacao do 4-fluoro-2-< { (4-metoxi-2-piridinil)-metil}-sulfinil>-1h-benzimidazol e de composicoes farmaceuticas que o contem - Google Patents

Processo para a preparacao do 4-fluoro-2-< { (4-metoxi-2-piridinil)-metil}-sulfinil>-1h-benzimidazol e de composicoes farmaceuticas que o contem

Info

Publication number
PT92649A
PT92649A PT92649A PT9264989A PT92649A PT 92649 A PT92649 A PT 92649A PT 92649 A PT92649 A PT 92649A PT 9264989 A PT9264989 A PT 9264989A PT 92649 A PT92649 A PT 92649A
Authority
PT
Portugal
Prior art keywords
sulfinyl
benzimidazole
pyridinyl
fluoro
methoxy
Prior art date
Application number
PT92649A
Other languages
English (en)
Other versions
PT92649B (pt
Inventor
Arne Elof Braendstroem
Per Lennart Lindberg
Gunnel Elisabeth Sunden
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE19888804629A external-priority patent/SE8804629D0/xx
Priority claimed from SE8902170A external-priority patent/SE8902170D0/xx
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of PT92649A publication Critical patent/PT92649A/pt
Publication of PT92649B publication Critical patent/PT92649B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT92649A 1988-12-22 1989-12-21 Processo para a preparacao do 4-fluoro-2-< { (4-metoxi-2-piridinil)-metil}-sulfinil>-1h-benzimidazol e de composicoes farmaceuticas que o contem PT92649B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19888804629A SE8804629D0 (sv) 1988-12-22 1988-12-22 New therapeutically active compounds
SE8902170A SE8902170D0 (sv) 1989-06-16 1989-06-16 Therapeutically active compounds

Publications (2)

Publication Number Publication Date
PT92649A true PT92649A (pt) 1990-06-29
PT92649B PT92649B (pt) 1995-09-12

Family

ID=26660387

Family Applications (1)

Application Number Title Priority Date Filing Date
PT92649A PT92649B (pt) 1988-12-22 1989-12-21 Processo para a preparacao do 4-fluoro-2-< { (4-metoxi-2-piridinil)-metil}-sulfinil>-1h-benzimidazol e de composicoes farmaceuticas que o contem

Country Status (27)

Country Link
US (1) US5025024A (pt)
EP (1) EP0449935B1 (pt)
JP (1) JP2793905B2 (pt)
KR (1) KR910700248A (pt)
CN (1) CN1028233C (pt)
AT (1) ATE110723T1 (pt)
AU (1) AU639429B2 (pt)
BG (1) BG60101B2 (pt)
CA (1) CA2005980C (pt)
CS (1) CS276361B6 (pt)
DE (1) DE68917937T2 (pt)
DK (1) DK122191A (pt)
EG (1) EG19302A (pt)
FI (1) FI913034A7 (pt)
GR (1) GR1000316B (pt)
HU (1) HUT57204A (pt)
IE (1) IE64199B1 (pt)
IL (1) IL92799A (pt)
LV (1) LV10267B (pt)
MY (1) MY129946A (pt)
NO (1) NO178336C (pt)
NZ (1) NZ231874A (pt)
PH (1) PH27446A (pt)
PL (1) PL160767B1 (pt)
PT (1) PT92649B (pt)
WO (1) WO1990006924A1 (pt)
YU (1) YU47338B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
WO2003063840A2 (en) * 2002-01-25 2003-08-07 Santarus, Inc. Transmucosal delivery of proton pump inhibitors
TWI367759B (en) * 2003-02-20 2012-07-11 Santarus Inc A novel formulation, omeprazole antacid complex-immediate release, for rapid and sustained suppression of gastric acid
TWI398273B (zh) * 2003-07-18 2013-06-11 Santarus Inc 用於抑制酸分泌之醫藥調配物及其製備及使用之方法
AR045061A1 (es) * 2003-07-18 2005-10-12 Santarus Inc Formulacion farmaceutica y metodo para tratar trastornos gastrointestinales causados por acido
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (pt) * 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
HU195220B (en) * 1983-05-03 1988-04-28 Byk Gulden Lomberg Chem Fqb Process for production of new fluor-alkoxi-benzimidasole-derivatives and medical compositions containig them
JPS6150979A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
US4738975A (en) * 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
NZ222495A (en) * 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
FI96860C (fi) * 1987-06-17 1996-09-10 Eisai Co Ltd Analogiamenetelmä lääkeaineena käytettävän pyridiinijohdannaisen valmistamiseksi

Also Published As

Publication number Publication date
JP2793905B2 (ja) 1998-09-03
KR910700248A (ko) 1991-03-14
GR1000316B (el) 1992-06-25
IE894050L (en) 1990-06-22
ATE110723T1 (de) 1994-09-15
YU47338B (sh) 1995-01-31
PH27446A (en) 1993-07-02
IL92799A (en) 1994-01-25
EP0449935B1 (en) 1994-08-31
FI913034A0 (fi) 1991-06-20
LV10267A (lv) 1994-10-20
CS734389A3 (en) 1992-01-15
MY129946A (en) 2007-05-31
IL92799A0 (en) 1990-09-17
AU639429B2 (en) 1993-07-29
GR890100833A (en) 1991-03-15
NO178336C (no) 1996-03-06
PT92649B (pt) 1995-09-12
YU242789A (en) 1991-04-30
NO178336B (no) 1995-11-27
WO1990006924A1 (en) 1990-06-28
IE64199B1 (en) 1995-07-12
DE68917937T2 (de) 1995-01-05
LV10267B (en) 1995-02-20
NO912414L (no) 1991-08-06
CS276361B6 (en) 1992-05-13
FI913034A7 (fi) 1991-06-20
EG19302A (en) 1994-11-30
DK122191D0 (da) 1991-06-21
DE68917937D1 (de) 1994-10-06
PL160767B1 (pl) 1993-04-30
BG60101B2 (bg) 1993-10-29
NZ231874A (en) 1992-05-26
CA2005980C (en) 1999-07-13
AU4813290A (en) 1990-07-10
DK122191A (da) 1991-06-24
US5025024A (en) 1991-06-18
HU901095D0 (en) 1991-09-30
CA2005980A1 (en) 1990-06-22
EP0449935A1 (en) 1991-10-09
CN1043937A (zh) 1990-07-18
NO912414D0 (no) 1991-06-20
JPH04502460A (ja) 1992-05-07
CN1028233C (zh) 1995-04-19
HUT57204A (en) 1991-11-28

Similar Documents

Publication Publication Date Title
SE8804629D0 (sv) New therapeutically active compounds
PT92647A (pt) Processo para a preparacao de 5-cloro-2-&lt; { (3,4-dimetoxi-2-piridinil)-metil}-sulfinil&gt;-1h-benzimidazol e de composicoes farmaceuticas que o contem
PT83647B (pt) Processo para a preparacao de novos derivados de benzimidazole com actividade farmacologica e de composicoes farmaceuticas que os contem
FI870219A0 (fi) Hypoglykemiska tiazolidindioner.
MX9206305A (es) Bifenilpiridonas substitutas, procedimiento para su obtencion y medicamento que los contiene.
PT84218B (pt) Processo para a preparacao de 5,6-dihidro-2-(fenilo substituido)-1,2,4-triazina -3,5(2h,4h)-dionas e de composicoes farmaceuticas que as contem
PT92649A (pt) Processo para a preparacao do 4-fluoro-2-&lt; { (4-metoxi-2-piridinil)-metil}-sulfinil&gt;-1h-benzimidazol e de composicoes farmaceuticas que o contem
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
PT101725A (pt) Processo para a preparacao de um composto de diarilo anti-aterosclerotico e de composicoes farmaceuticas que o contem
PT92146A (pt) Processo para a preparacao do inibidor de glicosidade salbostatina e de composicoes farmaceuticas que a contem
PT99435A (pt) Processo para a preparacao de derivados de amino-sulfonil-ureia e de composicoes farmaceuticas que os contem
CO4940448A1 (es) Modificacion a cristal de una sustancia de medicamento
DE3875611D1 (de) Pharmazeutische zusammensetzungen.
PT989994E (pt) Derivados de estreptograminas, a sua preparacao e as composicoes que os contem
SE8900685D0 (sv) New compounds
ECSP982677A (es) Fosfato de tetrahidrofurano antifungal
JO1664B1 (en) The compound has the effect of immobilizing gastric acid and the process of preparing it

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19950509

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19971130